Trials / Not Yet Recruiting
Not Yet RecruitingNCT06932289
Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- VA Greater Los Angeles Healthcare System · Federal
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
It is a 12-week study. The participants will follow three different diets, and during each diet period, and the participants will wear our device, and blood samples will be collected.
Detailed description
The investigators will conduct a randomized, controlled crossover intervention study. The investigators will enroll 54 participants, aged \>18 years, BMI \>25 kg/m2 with metabolic syndrome. During the first phase, all participants will consume their habitual diet for 2 weeks to establish baseline. Then participants will be randomized to either a Mediterranean diet (MED), high-fat/low carb diet (HF/LC), or low-fat diet (LF) for 14 days with 2 weeks washout between the different diets. The wearable system will monitor basal levels and the changes for glucose, cholesterol, TG, and NO through sweat analysis and HR, HRV, and PWV for carotid arterial stiffness during each diet intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF) | Participants will be randomized to either Mediterranean diet (MED), high-fat/low carb diet (HF/LC), or low-fat diet (LF). |
| DEVICE | The integrated sweat sensor and vascular sensor (wearable) | The integrated sweat sensor and vascular sensor will be worn of each diet period. |
| DEVICE | continuous glucose monitor (CGM) | A continuous glucose monitor (CGM) will be placed on the patients during each diet period. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2029-04-30
- Completion
- 2029-05-01
- First posted
- 2025-04-17
- Last updated
- 2025-04-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06932289. Inclusion in this directory is not an endorsement.